Yongxi Zhang
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies 17
- SARS-CoV-2 and COVID-19 Research 9
- Neurology top 1%
- Long-Term Effects of COVID-19 11
- Oncology top 5%
- COVID-19 and healthcare impacts 6
- Viral-associated cancers and disorders 5
- Modeling and Simulation top 5%
- Dermatology top 5%
-
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 5
-
- Immune cells in cancer 5
- Cited by
- Infectious DiseasesNeurologyOncology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yongxi Zhang
51 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Infectious Diseases 2.2k
- Neurology 1.1k
- Oncology 560
- Modeling and Simulation 84
- Dermatology 150
Countries citing papers authored by Yongxi Zhang
This map shows the geographic impact of Yongxi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongxi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongxi Zhang more than expected).
Fields of papers citing papers by Yongxi Zhang
This network shows the impact of papers produced by Yongxi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongxi Zhang. The network helps show where Yongxi Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongxi Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 18 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 71 | |
| 13 | 2020 | 339 | |
| 14 | 2020 | 14 | |
| 15 | 2020 | 12 | |
| 16 | 2020 | 8 | |
| 17 | 2020 | 6 | |
| 18 | 2017 | 25 | |
| 19 | Candida glabrata:epidemiology and mechanism of antifungal resistance | 2010 | 0 |
| 20 | 2010 | 14 |
About Yongxi Zhang
Yongxi Zhang is a scholar working on Infectious Diseases, Neurology and Biological Psychiatry, having authored 56 papers that have together received 3.0k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (17 papers), Long-Term Effects of COVID-19 (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 and healthcare impacts (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (5 papers), Hepatitis B Virus Studies (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Neurology (1.1k citations) and Oncology (560 citations). Yongxi Zhang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Pingzheng Mo, Qiu Zhao, Yong Xiong, Liping Deng, Zhiyong Ma, Shihui Song, Haizhou Wang, Fan Wang, Jiayan Nie and Shicheng Gao. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.